Among the admitted patients, 34.6% of 240 patients reported anemia, of which 9.6% had severe anemia (Hb <8 gm/dl) and 14.6% moderate anemia (Hb – 8-9.9 gm/dl). This evidence concerns the gene GSTM1 and anemia.